Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
APOTEA.STthis companyApotea AB	SEK 105.60	41.92×	11.37×	1.33×	21.39×	-66.8%	26.9%	4.2%	3.2%	27.1%	19.9%	1.2%	0.39×	0.71×	25.31×	1.28×	0.0%	4	9.34	3	B+
ERMA.STEnorama Pharma AB (publ)	SEK 0.76	-1.77×	-5.66×	48.45×	-2.1×	-104.0%	-2255.6%	-2268.0%	-2743.3%	320.4%	264.9%	-44.7%	0×	0.05×	-4.91×	0.25×	0.0%	2	-29.47	2	C
HAYPP.STHaypp Group AB (publ)	SEK 153.20	103.17×	6.52×	1.14×	18.98×	-36.7%	2.8%	2.8%	1.1%	6.3%	11.4%	3.0%	0.28×	0.56×	6.01×	1.27×	0.0%	4	7.8	2	C+
LYKO-A.STLyko Group AB	SEK 114.80	-698×	4.68×	0.54×	12.35×	3.5%	41.9%	1.9%	-0.1%	-0.7%	4.1%	10.1%	3.1×	3.84×	0.93×	0.78×	0.0%	6	2.21	2	C+
NNH.STNew Nordic Healthbrands AB	SEK 15.05	17.58×	1.39×	0.25×	9.26×	-27.5%	2.8%	2.6%	1.4%	7.9%	7.1%	5.3%	0.35×	1.1×	5.65×	1.6×	0.0%	3	2.82	3	B+
Peer median	—	7.9×	3.04×	0.84×	10.8×	-32.1%	2.8%	2.3%	0.5%	7.1%	9.3%	4.1%	0.31×	0.83×	3.29×	1.02×	0.0%	4	2.52	2	—